Description
Description
The combination of Empagliflozin and Linagliptin in Erlina tablets provides complementary mechanisms of action to help improve glycemic control in patients with type 2 diabetes mellitus. Empagliflozin works by promoting the excretion of excess glucose in the urine, while Linagliptin works by increasing insulin secretion and decreasing glucagon release from the pancreas.
Composition
Each film coated tablet contains:
- Empagliflozin: 10 mg
- Linagliptin: 5 mg
Suggested Usage
- Use only as directed by the physician.
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.
